Advertisement
Screener

Statera Biopharma, Inc. Proceeds from Stock Options Exercised

Statera Biopharma, Inc. Proceeds from Stock Options Exercised

Statera Biopharma, Inc. reported Proceeds from Stock Options Exercised of $12.39 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2015-02-27.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromStockOptionsExercised · last filed 2015-02-27

  • Statera Biopharma, Inc. proceeds from stock options exercised for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
  • Statera Biopharma, Inc. proceeds from stock options exercised for the quarter ending 2013-09-30 was $0.00.
  • Statera Biopharma, Inc. proceeds from stock options exercised for the quarter ending 2012-12-31 was $950.00, a 81.99% decline year-over-year.
  • Statera Biopharma, Inc. proceeds from stock options exercised for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
  • Statera Biopharma, Inc. proceeds from stock options exercised for fiscal 2013 was $12.39K, a 421.77% increase from fiscal 2012.
  • Statera Biopharma, Inc. proceeds from stock options exercised for fiscal 2012 was $2.38K, a 99.55% decline from fiscal 2011.
  • Statera Biopharma, Inc. proceeds from stock options exercised for fiscal 2011 was $532.41K, a 40.97% decline from fiscal 2010.
  • Statera Biopharma, Inc. proceeds from stock options exercised for fiscal 2010 was $901.91K, a 148.56% increase from fiscal 2009.
Period endProceeds from Stock Options Exercised 3 monthProceeds from Stock Options Exercised 6 monthProceeds from Stock Options Exercised 9 monthProceeds from Stock Options Exercised 12 month
2013-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$0.00
derived: sum of 2 quarters · filed 2015-02-27
$12.39K
10-K · filed 2015-02-27
2013-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$12.39K
10-Q · filed 2014-11-10
2013-06-30$12.39K
10-Q · filed 2014-08-11
2012-12-31$950.00
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$950.00
derived: sum of 2 quarters · filed 2015-02-27
$950.00
derived: sum of 3 quarters · filed 2015-02-27
$2.38K
10-K · filed 2015-02-27
2012-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
$0.00
derived: sum of 2 quarters · filed 2013-11-08
$1.43K
10-Q · filed 2013-11-08
$6.70K
derived: sum of 4 quarters · filed 2014-03-17
2012-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
$1.43K
10-Q · filed 2013-08-09
$6.70K
derived: sum of 3 quarters · filed 2014-03-17
$11.57K
derived: sum of 4 quarters · filed 2014-03-17
2012-03-31$1.43K
10-Q · filed 2012-05-07
$6.70K
derived: sum of 2 quarters · filed 2014-03-17
$11.57K
derived: sum of 3 quarters · filed 2014-03-17
$226.49K
derived: sum of 4 quarters · filed 2014-03-17
2011-12-31$5.27K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17
$10.15K
derived: sum of 2 quarters · filed 2014-03-17
$225.06K
derived: sum of 3 quarters · filed 2014-03-17
$532.41K
10-K · filed 2014-03-17
2011-09-30$4.88K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$219.79K
derived: sum of 2 quarters · filed 2012-11-09
$527.13K
10-Q · filed 2012-11-09
$1.16M
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30$214.91K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$522.26K
10-Q · filed 2012-08-09
$1.16M
derived: sum of 3 quarters · filed 2013-03-18
$1.32M
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$307.35K
10-Q · filed 2012-05-07
$945.18K
derived: sum of 2 quarters · filed 2013-03-18
$1.11M
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31$637.83K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-18
$802.27K
derived: sum of 2 quarters · filed 2013-03-18
$901.91K
10-K · filed 2013-03-18
2010-09-30$164.43K
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2011-11-14
$264.08K
10-Q/A · filed 2011-11-14
2010-06-30$99.64K
10-Q · filed 2011-08-09
2009-12-31$362.86K
10-K · filed 2012-03-13